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Abstract
Core‐shell model drug carriers on two nanoscale size levels have been applied in cell 
culture studies and focused on Toxoplasmosis therapy. In synthesis, a seed of rhoda‐
min B‐labelled polystyrene latex particles was coated by polybutyl cyanoacrylate under 
physical inclusion of two different new drugs against Toxoplasmosis. Drug‐loaded and 
drug‐free core‐shell model drug carriers were added to a cell culture of human macro‐
phages, infected by Toxoplasma gondii, following an infection plan. Drug release from 
the carriers had been studied before by enzymatic degradation by means of pork liver 
esterase. Particle size decrease by degradation was investigated in a UV/VIS spectrometer 
via transmission measurements. Drug release profiles were obtained by HPLC  studies. 
The dynamics in the population of infected human macrophages, T. gondii as well as 
model drug carrier numbers were registered by an FACS (fluorescence‐activated cell 
sorter). As main result, the drug‐free references in the two series of core‐shell model drug 
carriers achieved ca.85% of the observed maximum in Toxoplasmosis therapy efficiency. 
These data were correlated with an immune stimulant effect on the side of the human 
macrophages, caused by the cell uptake of colloidal substrate, foreign to the body.
Keywords: toxoplasmosis, nanoparticles, model drug carriers, human macrophages, 
cell culture, infection, therapy efficiency, immune stimulation
1. Introduction
Nanoparticles (NPs) are a tool for specifically targeting drugs or diagnostics to selected  tissues 
or cell types [1–3]. Their use in cancer research and therapy is of special interest [4–9] as  well 
as to overcome the blood‐brain barrier [10, 11]. At least in theory, they are a tool to optimise 
pharmacological data such as drug release, tissue specificity and even cell specificity [2].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In some cases, drug crystals have been used successfully as nanocarriers [12, 13]. NPs com‐
posed of polymers may be loaded with drugs which they release in a controlled manner, or 
they are coated with molecules which give them specific surface characteristics to bind and 
be taken up by certain cells. Despite these attractive goals and 30 years of research, there are 
no polymeric nanoparticles in practical, pharmaceutical use. There is hope to apply nanopar‐
ticles to deliver drugs across the blood‐brain barrier [10, 14, 15].
The reasons for this obvious failure include following: first, the unresolved problem of 
cytotoxicity of several nanocarrier types [16], low drug loading and insufficient delivery of 
the bound drug and lack of production facilities to supply demand.
The problem of toxicity could be overcome at least partially by high selectivity with regard 
to the cells by which the NPs are taken up. Such a strategy is especially interesting in the case 
of cells, infected with microbes which only multiply intracellularly, such as viruses and some 
parasites, as these often alter the surface of the host cell, thereby offering the specific targets 
needed. In this case, even toxic NPs could be useful, as they would exert their toxicity mainly 
or even better only in or against infected cells which would inhibit the multiplication of the 
pathogens and destroy them.
At the moment, there are some data showing that tissue specificity may be achieved. One of 
the interesting targets is the endothelial barrier of the brain. Despite the big potential [17], 
there are no data concerning infected cells. As it is important to develop drugs against intra‐
cellular parasites such as Toxoplasma or Leishmania, therefore the goal is to establish a system 
which would allow to trace the fate of nanoparticles in infected cell cultures. It should be 
possible to evaluate the cell and parasite proliferation and the differential uptake of NPs.
A fluorescence‐activated cell sorter (FACS) represents a useful tool to measure particles which 
differ in size and more importantly, in fluorescence [18]. Thus, it is possible to count extra‐
cellular parasites and their host cells separately, if they differ in size. To find the intracellu‐
lar parasites and to differentiate between infected and non‐infected cells, green fluorescent 
protein‐transfected parasites were used. In the past, it was shown that it is possible to follow 
the fate of Leishmania in a cell culture which is conventionally treated (by adding drugs at the 
necessary concentration) [19].
Because the FACS is able to discriminate between fluorescences of different wave lengths, 
the purpose of this study was to establish a system with stained NPs as an additional react‐
ing partner [20]. In the case of Leishmania, only phagocytic cells, mainly macrophages, act as 
host cells and the parasite becomes internalised through phagocytosis. There are some data 
that NPs without drugs may even interfere with normal white blood cell functions, including 
phagocytosis.
As NPs are recognised as foreign structures, they are eliminated by phagocytising cells 
[21, 22]. Thus, it should be easier to treat microorganisms which multiply within macro‐
phages, because the nanoparticles would be concentrated automatically in the desired target 
cells. An example for this strategy is Leishmania [23]. Another interesting goal of nanopar‐
ticle research is targeting NPs to the brain [11, 14, 24]. Toxoplasma gondii offers a possibility 
to combine these aims. T. gondii is a parasite which multiplies in different cell types  including 
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macrophages and phagocytising cells in the brain [25]. The main problems in treatment of 
toxoplasmosis are infections during pregnancy and Toxoplasma encephalitis in the case of 
immunocompromised patients [25–28]. In normal Toxoplasma infections, the multiplication 
of the parasites is stopped by the immune system, but cysts remain in all formerly infected 
tissues including the brain, serving as a source for exacerbations. Therefore, efficient treat‐
ment of all infected cells to prevent cyst formation would be an interesting goal. Thus, we 
started our experiments with NPs in T. gondii‐infected cultures, knowing that T. gondii has a 
completely different mode of penetration which is mostly independent of the support of the 
host cell [29].
To come closer to in vivo conditions and to make it easy to observe an effect, the culture 
should work for at least 3 days to allow several cycles of multiplication.
Initially, all experiments with FACS should be controlled by microscopy, to prove that the 
interpretation of the FACS data is consistent with the images seen under the microscope.
2. Results and discussion
The established and considered system consisted of three components: nanoparticles, para‐
sites and cells which differed in size and shape. However, there were also infected cells, cells 
loaded with nanoparticles and infected cells with nanoparticles which should be differenti‐
ated as well. To trace the fate of parasites and nanoparticles with FACS, they had to be stained 
with dyes which are distinguishable from each other. Because the green fluorescent protein, 
Toxoplasma was transfected with, shows fluorescence in green and yellow [33, 34] a red dye to 
stain the nanoparticles gave sufficient results. Of the dyes tested, rhodamine B gave the best 
results. The intensity of fluorescence corresponds with the amount of dye, fixed inside the 
core of the NPs and should increase exponentially (to the third) with the increasing radius 
of the NPs. In larger particles, however, there seems to be a quenching, as light is unable to 
penetrate from the core of the particle to the surface.
Next, a broader spectrum of NPs of different sizes was tested to see, which gave the best 
results. To be able to compare the FACS data with microscopical counting, the NPs had to 
be larger than 100 nm; otherwise, microscopical identification, especially of intracellular 
particles, would be impossible. In Table 1, one of the two best candidates is shown. As the 
results obtained with the two different NPs in these experiments were identical, only data 
with MC81cs are shown here.
The nanoparticle suspensions were homogeneous in size, checked by electron microscopy—
data not shown—and were shown to be non‐toxic, by measuring growth of cell cultures in 
their presence.
Figure 1A shows an infected cell in the presence of NPs. NPs with diameters between 200 
and 300 nm were focused on as they were perfect for these purposes, being visible under a 
microscope, and therefore allowing the opportunity to compare microscopically the results, 
obtained with FACS with the situation in the cell culture.
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The same area photographed using different filters: the arrow points to a macrophage cell 
infected with one Toxoplasma cell.
a. Three channel photography (FITC/PI/neutral): NPs are attached to the macrophage, and 
some are scattered around.
b. Two channel photography (FITC/PI): the parasite inside the cell is clearly visible.
c. One channel photography (FITC): only the parasite (green) is visible.
d. One channel photography (PI): the parasite is invisible, the cell appears red as a result of 
uptaken NPs, and some extracellular NPs are visible.
Figure 1B–D demonstrates how different filters are able to distinguish the dyes used. In 
a first series of experiments, different amounts of NPs added to cell culture were tested 
with the result that approximately 60,000 particles per cell gave measurable and reproduc‐
ible results in this system. Most of the NPs were phagocytised by the cells within the first 
few hours.
As parasites not only infect cells and multiply—increasing in number in an unpredictable 
way— they will also destroy host cells, thereby diminishing their number.
To calibrate the exact increase or decrease in the different components, ‘Perfect Counting 
Beads’ (Caltag Laboratories) were added before FACS scan and all data were adjusted to the 
beads count.
The particle size (FSC‐x‐axis) and granularity (SSC‐y‐axis) were determined. In A, 
toxoplasmas‘and in B, macrophages were counted in relation to beads in order to calculate 
MC81
Core Core‐shell (cs) Cs + pentamidine
Z‐ave (nm) 133.1 213.4 221
PI 0.065 0.046 0.071
ZP (mV) pH Distilled 
water
−93.20 5.52 −84.79 5.5 −79.70 5.55
10E‐3M 
NaCl
−70.33 5.53 −63.40 5.51 −61.66 5.51
10E‐2M 
NaCl
−50.85 5.54 −30.60 5.51 −29.00 5.45
Surface charge density (μC/cm2) −2.54 −0.93 −0.96
MC81c MC81cs
No drug Pentamidine Spiramycin
Size (nm) 133.1 213.4 222.1 198.1
PI 0.065 0.046 0.071 0.04
Table 1. Nanoparticle properties (mean particle diameter [z‐average] and polydispersity index from dynamic light 
scattering, zetapotential [ZP] from particle electrophoresis).
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absolute numbers. The beads are always seen in the same position. In parallel, the particles 
were characterised by fluorescence (see Figure 3).
Figure 2 shows an example of data obtained with a culture of J744‐A1 cells infected with T. gon‐
dii. Each sample had to be measured twice: once to count the free parasites (Figure 2A) and a sec‐
ond time to count the cells (Figure 2B) separated by their size (FSC) and their granularity (SSC).
For analysis, the counted cells were sorted by fluorescence then. The series of dot blots in 
Figure 3 compares uninfected, untreated control cells (A), infected cells (B), infected cells 
treated with unloaded nanoparticles (C), uninfected cells treated with unloaded NPs (D) and 
infected cells treated with pentamidine‐loaded NPs (E).
The dot blots show changes in green fluorescence and granularity. In addition, the mean 
values of the particles in the gates are given in Table 2, as the numbers are hard to calculate 
from the images. The shift in the mean values is often more impressive than the density or 
position of the dots.
Figure 1. Situation in cell culture: macrophages, parasites and nanoparticles (NPs).
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Figure 2. Particle size (FSC‐x‐axis) and granularity (SSC‐y‐axis) of (A) Toxoplasma cells and (B) macrophages population.
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Figure 3. Granularity (SSC) and green fluorescence (FL1) of non‐infected, untreated cells (A), infected, untreated cells 
(B), infected and treated with pure nanoparticles (C), uninfected cells, treated with nanoparticles (D) and infected cells, 
treated with pentamidine‐loaded nanoparticles (E), given after 1 day of incubation.
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Figure 3A illustrates the fluorescence of the macrophages of the cell control with its character‐
istic unspecific autofluorescence. The presence of Toxoplasma and/or NPs induces a movement 
into the area of higher fluorescence (Figure 3B–E). Whereas the Toxoplasma induces a stron‐
ger shift into the green fluorescence (Figure 3B), the NPs induced a smaller one (Figure 3D) 
which is an effect of an unspecific stimulation of the cells resulting in an increased autofluo‐
rescence [30].
The corresponding Table 2 shows the percentage of particles in the gate for non‐infected cells 
(R1) and the percentage in the gate of infected cells (R2) as well as the corresponding mean 
values (mean) and geometrical mean values (G‐M).
Green fluorescence is represented on the x‐axis and granularity on the y‐axis.
Macrophages, activated by nanoparticles, have a basic fluorescence which is at least partially 
an indicator of their activity [36]. Thus, controls of cells, treated only with nanoparticles, are 
essential. For data processing, other combinations may be selected, such as granularity or red 
fluorescence. There is always an overlap of data however, and the interpretation of the blots 
must be proofread against the mean values of the particles within the gates—here given in 
the corresponding tables.
In the following series of experiments, a cell system was established in a manner that after 
infection on day zero, there is a continuous multiplication of Toxoplasma at least until day 
three. Defined concentrations of cells were put into wells, and parasites in different ratios 
were added for this purpose. The ratio parasite to cell is given as MOI (multiplicity of infec‐
tion). All tests were carried out in three wells in parallel, and all experiments were carried out 
at least twice. The most promising results were obtained with MOI's of 1–10.
Figure 4 shows the results of one of these experiments. MOI's of 10, 5, 2 and 1 were used, and 
free parasites (A), total cells (B) and infected cells (C) were determined at the first, second 
and third day after infection. There was a large increase in free parasites over the 3 days with 
MOI's of 10 and 5, a moderate increase with an MOI of 2 and almost no increase with an MOI 
of 1 (Figure 4A). In parallel, there was no such strong increase in total cell number as with 
the uninfected controls (Figure 4B). With the high MOI's of 10 and 5, there was a decrease at 
day two and an increase at day three. Only with MOI's of 1 and 2, there was a slight increase 
in cells over the 3 days. The number of infected cells indicates that with a MOI of 10 and 5, 
almost all cells were infected, whereas with MOI'of 2 and 1, many cells remained uninfected 
until day three (compare Figure 4B and C).
It was shown that MOI 2 is most appropriate for these tests, because there was an increase in 
the parasites and of the cells over the 3 days.
In a culture of infected cells, running for at least 3 days, there will be individual death of cells 
and parasites. Some of the free Toxoplasma in the culture will die and—as the infected cells dis‐
integrate after liberating multiplied parasites—will shift into the debris. Thus, there will be an 
unpredictable increase or decrease in cell counts. To differentiate between an increase of non‐
infected cells and a loss of infected cells, both of which result in an increase in the percentage 
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of non‐infected cells, it was necessary to determine the total number of cells and the propor‐
tion of infected and non‐infected cells in relation to the cell input on day zero. Before mea‐
suring, cells were fixed with paraformaldehyde, and after ‘Perfect Counting Beads’ (Caltag 
Laboratories) were added, the samples were counted.
Experiment R1 % R1 X mean R1 X G–M R2% R2 X mean R2 X G–M
A C 98.84 8.35 7.35 1.16 102.68 77.60
B C + T 50.83 23.42 20.62 49.17 108.24 91.94
C C + T + NPs 73.05 18.68 16.16 26.95 165.08 116.78
D C + NPs 85.46 13.72 11.16 14.54 88.33 80.10
E C + T + NPs + P69.55 19.58 16.84 30.45 103.65 86.43
Exp.: part of the experiment corresponding to A to E; R%: percent of counts in this gate; R1 X mean: mean value of counts 
in gate 1; R1 X G‐M: geometrical mean value of counts in gate 1; R2 X mean: mean value of counts in gate 2; R2 X G‐M: 
geometrical mean value of counts in gate 2.
Table 2. Granularity (SSC) and green fluorescence (FL1) with the corresponding values of Figure 3.
Figure 4. Influence of multiplicity of infection (MOI) 1.36 × 105 cells per ml was infected with different multiplicities 
of infection (10, 5, 2 and 1). A number of free parasites (A), total cell number (B) and number of infected cells (C) were 
determined over 3 days.
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There was an indication that even unloaded NPs have an inhibitory effect. To prove this, the 
influence of pentamidine‐loaded and unloaded nanoparticles on Toxoplasma‐infected cell cul‐
tures was determined. Figure 5 shows the histograms in each case for day 2 of non‐infected 
cells (A), infected untreated cell controls (B), cells only treated with NPs (C), infected cells 
treated with unloaded NPs (D) and pentamidine‐loaded NPs (E). The histograms show the 
changes in green fluorescence (FL1) and number of counts. One table with all data obtained 
(Figure 5A) is shown as an example of how CellQuest® analyses data. Data of corresponding 
tables, with the mean values of the gates for all 3 days, are given in Table 3. It is shown that the 
presence of Toxoplasma induced a shift to higher fluorescence. Comparing the data of infected 
cells, treated with pentamidine‐loaded nanoparticles with those treated with unloaded 
nanoparticles, demonstrates that nanoparticles alone had an effect on T. gondii multiplication.
Simply comparing the mean values of M2 (the gate with the infected cells) would lead to 
a misinterpretation: the geometrical mean value would indicate that NPs even enhance 
Toxoplasma multiplication (106.69 vs. 86.41‐labelled with ‘1’ in Table 3), and the median 
would also suggest this (84.26 vs. 77.04 labelled with ‘2’ in Table 3).
By looking at the percentage, one sees that with NPs, there was an increase in cells in the gate 
of non‐infected cells (M1: 71.0 vs. 49.5% labelled with ‘3’ in Table 3) and as the mean value of 
all cells indicates, there was an inhibition by unloaded NPs visible as reduction in green fluo‐
rescence (57.48 vs. 63.41 labelled with ‘4’ in Table 3). The median indicates that the inhibition 
was substantially (22.27 vs. 43.32 labelled with ‘5’ in Table 3).
The mean value of the green fluorescence marker reflects the parasitic load, as fluorescence is 
proportional to parasite number. Thus, few cells with high numbers of parasites may increase 
the mean value despite the fact that there were lots of non‐infected cells. The median indi‐
cates the shift of the population towards infected or non‐infected cells. The closer the median 
of infected, treated cells come to non‐infected control cells, the better the treatment success. 
The geometrical mean gives some information, concerning the heterogeneity, but avoids the 
overestimation of exceptionally heavy infected single cells.
By measuring 10,000 cells, FACS offered the opportunity to statistically treat these data in 
different ways, resulting in a more complex interpretation. In addition to this evaluation of 
data, one had to take into account that nanoparticles are known to stimulate the macrophages 
[30–32]. As an increase in unspecific fluorescence was seen, an inhibition of Toxoplasma 
growth by unloaded nanoparticles was not surprising.
The explanation was that the nanoparticles counteracted the suppression of activities caused 
by the parasites [33], and this unspecific stimulation of macrophages by nanoparticles was 
more effective than the inhibition of parasites within downregulated host cells.
As cells, treated with nanoparticles, were always used as controls to estimate the unspecific 
increase in fluorescence, it was realised that there was a substantial inhibition by unloaded 
nanoparticles in all experiments.
In an additional series of experiments, the effect of nanoparticles without any drug was 
specifically proven. Data of an experiment to determine the effect of particle number on the 
 multiplication of T. gondii during a period of 3 days are given in Figure 6.
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Figure 5. FACS counts of non‐infected, infected and NPs‐treated cell. Histograms are shown in each case for day 2 of 
non‐infected cells (A), infected untreated cell controls (B), cells only treated with NPs (C), infected cells treated with 
unloaded NPs (D) and pentamidine‐loaded NPs (E). The histograms show the changes in green fluorescence (FL1) and 
number (counts). M1 indicates the non‐infected cells and M2 the infected ones. (T = Toxoplasma gondii).
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1. day 2. day 3. day
All M1 M2 All M1 M2 All M1 M2
Cell control [%] 98.6 1.4 93.0 7.0 92.0 8.0
Mean 9.29 16.77 16.14
Geomean 7.30 7.08 70.91 12.57 11.11 66.29 10.23 8.68 65.62
Median 6.79 6.73 57.25 10.75 10.37 61.53 9.22 8.58 59.89
Infected cells [%] 35.0 65.0 33.0 67.0 49.53 50.5
Mean 160.49 127.46 63.414
Geomean 75.89 18.78 156.81 70.30 23.32 121.25 42.25 20.27 86.415
Median 73.63 19.81 145.90 66.12 25.71 103.66 43.325 22.07 77.042
Cells + NPs [%] 93.0 7.0 90.5 9.5 85.5 15.5
Mean 14.63 18.76 22.96
Geomean 10.06 8.77 67.19 13.70 11.60 65.49 13.21 9.81 74.96
Median 8.28 7.99 62.08 11.44 10.84 61.53 11.44 9.91 69.16
Cells + Toxopl. + NPs [%] 34.0 66.0 33.5 66.5 71.03 29.0
Mean 159.64 118.23 57.484
Geomean 76.71 19.57 156.14 142.73 23.22 117.34 27.56 15.92 106.691
Median 72.34 21.29 143.30 64.94 25.71 101.82 22.275 15.96 84.292
Cells + Toxopl.+ NPs 
(pentamidine‐loaded) [%]
37.0 63.0 35.0 65.0 69.0 31.0
Mean 157.60 115.67 43.75
Geomean 73.90 20.18 158.34 65.71 23.49 113.57 27.49 27.49 79.96
Median 67.93 21.48 144.60 61.80 25.71 95.60 25.95 17.31 68.54
1,2,3,4 and 5 refer to numbers in discussion.
Table 3. Mean values of total cells and gates of Figure 5. In addition to the mean values, the percentage of M1 and M2 of total cells for each part is given.
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Figure 6. Effect of different concentrations of NPs (MC81cs) on cell proliferation and of Toxoplasma gondii (T. g) 
growth. (A) A number of all remaining cells (infected and non‐infected) after 1, 2 and 3 days of infection and 
treatment. (B) A number of free (extracellular) Toxoplasma gondii. There are no Toxoplasma in NPs‐treated, non‐
infected cells. (C) A number of infected cells after treatment with different concentrations of NPs.
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Part A shows the increase in the infected and non‐infected cells with different NPs concentra‐
tions. As can be seen, NPs in a high concentration (conc.4) inhibited proliferation over the 
3 days. The lower concentrations led to a small increase on day two and a larger increase on 
day three. With infected cells, there was no difference between conc. 4 and 3, and only a slight 
decrease in cells with conc. 2. But with the lowest concentration, conc. 1, there was a decrease 
over the 3 days.
Part B shows the increase in Toxoplasma in the presence of NPs. Concentrations 4 and 3 sup‐
pressed the propagation of Toxoplasma. There was a reduced number of free Toxoplasma com‐
pared with the infection control. At concentrations 1 and 2 on the third day, there was a large 
increase in free Toxoplasma with concentrations even higher than in the untreated control.
Part C shows the number of infected cells which decreased at all NPs concentrations on day 
two and increased on the third day. The third concentration led to the smallest number of 
infected cells over the 3 days.
Cells were infected with an MOI of 2. The concentrations of NPs were as follows:
As discussed above, the effect of NPs was interpreted as activating the functions suppressed 
by Toxoplasma. On the other hand, there may be negative effects on macrophage functions, 
too [34]. Thus, in other cases (with other cells or with other parasites), the effect could be dif‐
ferent. If there is stimulation, a treatment with nanoparticles alone could have some influence 
on a Toxoplasma infection, as drug‐loaded particles have.
One way to prove this is to repeat these experiments in other, non‐phagocytising host cells. 
The problem is that they will not take up the nanoparticles as easily as the macrophages do. 
As there are other microorganisms which also multiply within macrophages, there could be 
other indications for this type of treatment.
In all experiments described so far, Toxoplasma and NPs were added simultaneously to the 
cells. When nanoparticles influence the activities of phagocytising cells, and T. gondii alters 
the host cell activities, it is interesting to ask, whether the presence of NPs or T. gondii inter‐
feres with the taking up of the other, is there some type of mutual exclusion? Thus, experi‐
ments were carried out with NPs, added four hours after infection with T. gondii, or cells were 
infected 4 h after treatment with NPs. There were no differences in the taking up of NPs or 
parasites or in the effect of treatment after 3 days. The slope of the parameters was simply 
shifted (data not shown).
In the future, one will see, whether Leishmania major which in contrast to T. gondii are able 
to grow only in macrophages and are also inhibited by unloaded NPs. A few reports indicate 
that this should be true [21]. With Leishmania, first data in animal models were published [35, 
36]. The fact that Leishmania major multiplies only in phagocytising cells makes them even 
more interesting for a further use of nanoparticles.
Conc 1: 118,000 NPs/cell Conc 3: 24,000 NPs/cell
Conc 2: 60,000 NPs/cell Conc 4: 12,000 NPs/cell
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A question to be answered is, whether there is disintegration of nanoparticles by the host 
cells. There was fluorescence on the third day, what could be the result of dye released 
after disintegration? Microscopical observation revealed that nanoparticles were still pres‐
ent, at least the non‐degradable, fluorescence‐labelled polystyrene cores of these core‐shell 
nanoparticles.
With the methods used, a disintegration of the nanoparticles could not be demonstrated in 
detail as it should start with the cleavage of the ester groups of the polymer shell by esterases 
which would not alter the structure in a way that could be seen with a microscope. As it only 
happens inside the cells, this alteration cannot be found with FACS, as there is no change 
in granularity.
As the core particles remain undigested, granularity will indicate the presence of particles. In 
the case that there would be no disintegration, this may be an advantage of an in vitro system 
using phagocytising cells, as the activation will persist. The consequences for in vivo condi‐
tions remain to be determined. Allen showed in 1988 that repeated application of liposomes 
could led to an impairment of Kupffer cells in the liver and fixed macrophages in the spleen 
which remove most of these NPs [37].
Our aim was to establish a system which allows the observation of the interaction of 
nanoparticles and microorganisms, infecting a cell culture, because there should be dif‐
ference between infected and non‐infected cells which could be used for targeting. The 
results are very promising. As various cell lines are able to produce interleukins or other 
modulators, there is the possibility to characterise the influence of nanoparticles in even 
more detail.
The data that NPs without any drugs have the same effect as drug‐loaded NPs offer the 
opportunity to use NPs directly for treatment. Perhaps part of the effect of Atovaquone crys‐
tal nanoparticles in a Toxoplasma‐mouse model should be attributed to the effect of nanopar‐
ticles [13], rather than to the direct effect of the drug against the parasite.
3. Experimental part
3.1. Colloid and polymer chemistry
3.1.1. Preparation of nanoparticles
Core‐shell latex nanoparticles (MC81cs see Table 1) were synthesised by seeded, aqueous 
polymerisation of butyl cyanoacrylate onto polystyrene cores. Polystyrene cores were pre‐
pared by emulsion polymerisation of styrene in a water/ethanol mixture (16:1; v/v) in the 
presence of rhodamine B and purified by dialysis against deionised water. One gram of 
these core particles in water with a pH of 2 was used as seed for the polymerisation of 2 g 
butyl cyanoacrylate [38]. In the case of pentamidine loading, 5 mg pentamidine/g polymer 
was added to the polymerisation medium. Resulting core‐shell nanoparticles were purified 
by dialysis against de‐ionised water after neutralisation with sodium hydroxide (1 M aque‐
ous solution).
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3.1.2. Characterisation of nanoparticles
The particle size, determined as Z
ave
 (average particle diameter) and the polydispersity 
index (PI), was measured by photon correlation spectroscopy (PCS), using a Zetamaster S 
(Malvern Instruments). Electrophoretic mobilities were measured to reflect the effective sur‐
face charge (Zetamaster S, Malvern Instruments). For transformation into zeta potential, the 
Smoluchowski model for ideal smooth spheres was used. Measurements were carried out in 
ultra‐pure water (Millipore), 0.01 M NaCl solution and in 0.001 M NaCl solution.
Surface charge density was titrated by means of 0.1 mM PDADMAC solution (MW approx. 
100,000) at a combination of particle charge detector PCD‐03 pH (MÜTEK) and automatic 
titrator Titrino 716 (Metrohm). Purified, aqueous nanoparticle suspensions were stored in the 
refrigerator until use.
3.1.3. Beads
‘Perfect Counting Beads’ (Caltag Laboratories) were used to adjust the cell and T. gondii num‐
ber. Immediately before counting with FACS, a defined number of beads were added and for 
calculation of inhibition and growth, all cells and T. gondii were adjusted to the known bead 
concentration.
3.2. Biology of Infections
3.2.1. T. gondii GFP growth and experimental infection:
Tachyzoites of the RH (CAT‐GFP) strain of T. gondii (obtained from D. Soldati; Centre of 
Molecular Biology, Heidelberg University, Germany) were maintained in vitro in human epi‐
theloid carcinoma cells (HELA) by serial passage into RPMI medium supplemented with 10% 
FCS (Gibco‐BRL) twice a week (Gibco‐BRL).
Macrophages and parasites were counted in a Fuchs‐Rosenthal chamber and adjusted to the 
concentrations indicated. In most cases, macrophages of a concentration of 1.36 × 105 per ml 
were used and the multiplicity of infection (MOI) in most experiments was 2.
3.3. Cell culture work
3.3.1. Cell lines
Macrophages: The intracellular Toxoplasma infection studies were performed on J 774‐A1 
cells (mouse monocyte macrophages, ACC 170; German Collection of Microorganisms and 
Cell Cultures). The macrophages were grown in Dulbecco's MEM containing 10% heat‐inacti‐
vated foetal calf serum (Boehringer, Germany) at 37°C in 5% CO
2
 atmosphere.
3.3.2. FACS‐analysis
Parasites, infected cells and non‐infected cells were counted with FACS‐scan analytical flow 
cytometry and equipped with a 15 mV, 488 nm air‐cooled argon ion laser (Becton Dickinson). 
Multiparametric data were analysed using CellQuest® Software. Ten thousand ‘particles’, 
defined by size and granularity, were measured for each analysis.
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The optimised instrument parameters for the assay were as follows: forward scatter (E 00, 
log mode), side scatter (319 voltage, log mode) fluorescence 1 (FL1; 613 voltage, log mode) 
and fluorescence 2 (FL2; 528, log mode).
Each experiment was carried out in a triple manner and performed in a special labora‐
tory. The equipment was decontaminated with FACS‐safe solution (1% active chlorine, 
Becton Dickinson).
Adding formaldehyde to a final concentration of 0.2% resulted in a preservation of the 
samples. Samples could be stored for days in a refrigerator and be measured at a more 
convenient time.
3.3.3. Microscopy and photography
An epifluorescence microscope (Axioskop; Zeiss) was used to view the infection fate of J774 
A1 cells with T. gondii GFP. The microscope was equipped with a 50 W high‐pressure mer‐
cury lamp (HB050; Osram) and 10×, 40× and 100× objectives (Zeiss). Narrow band filter sets 
HQ‐F41‐007 and HQ‐F41‐001 (AHF Analysentechnik) were used to analyse the GFP and red 
signals, respectively, at a magnification of 1000×. Image processing was performed with a 
standard software package delivered with the instrument (Zeiss Axiovision 3.1).
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